©The Author(s) 2026.
World J Gastrointest Pharmacol Ther. Mar 5, 2026; 17(1): 112640
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112640
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112640
Table 1 Performance of deep learning models in endoscopic assessment of mucosal healing
| Ref. | Input | Model | Key performance metrics |
| Stidham et al[31] | Images | CNN | MES 0-1 vs MES 2-3: AUC = 0.97 |
| Ozawa et al[32] | Images | CNN | MES 0 vs MES 1-3: AUC = 0.86; MES 0-1 vs MES 2-3: AUC = 0.98 |
| Gottlieb et al[35] | Videos | RNN | EH by eMS: Accuracy = 95.52%; EH by UCEIS: Accuracy = 97.04% |
| Takenaka et al[34] | Images | DNUC | UCEIS ≤ 1: Accuracy = 90.1% |
| Higuchi et al[68] | Images1 | CNN | MES 0-3: Accuracy = 91.3%-99.4% |
| Yao et al[33] | Videos | CNN | MES 0-1 vs MES 2-3: Accuracy = 83.7% |
| Iacucci et al[47] | Videos | CNN | PICaSSO ≤ 3 (VCE): AUC = 0.94; UCEIS ≤ 1: AUC = 0.85 |
- Citation: Bilotta AJ, Trebilcock JA, Hebda NJ, Sasan CK, Cooper KM, Rupawala AH. Artificial intelligence in the management of inflammatory bowel disease: What’s next? World J Gastrointest Pharmacol Ther 2026; 17(1): 112640
- URL: https://www.wjgnet.com/2150-5349/full/v17/i1/112640.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v17.i1.112640